Document is current
Any future updates will be listed below
-
Authors
Weber, P.
Braß, P.
Jäger, J.
Jacquet, L.
Jansen, S.
Gäckler, A.
Jürgens, C.
Reinold, J.
Eisenberger, U.
Rath, P.-M.
Kribben, A.
Witzke, O.
Rohn, H.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 30 November 2024
Accepted: 14 February 2025
First Online: 10 March 2025
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose related to this study. Oliver Witzke is an editor of Infection and has received research funding, speaker honoraria, or travel support from the following companies: Amgen, Alexion, Astellas, AstraZeneca, Basilea, Biotest, Bristol-Myers Squibb, Correvio, Chiesi, Gilead, GSK, Hexal, Janssen, Dr. F. Köhler Chemie, MSD, Novartis, Roche, Pfizer, Sanofi, TEVA, and UCB.
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of the Medical Faculty of the University of Duisburg-Essen (Apporval No. 23–11437-BO).
